News|Articles|September 10, 2024
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
Author(s)WCG Clinical
The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
2
Applying AI to Reduce Administrative Burden Without Losing the Human Touch
3
Women as the Missing Voice in Parkinson’s Disease
4
Why Startup Timelines Are Worsening—and How to Reverse the Trend
5